SCHEMBL68224

SCHEMBL68224

Oc1ccc(Br)cc1Cc1cc(Br)ccc1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 4/20 0.54
HIF1A Q16665 3/20 0.54
HPGD P15428 3/20 0.54
CYP3A4 P08684 2/20 0.54
HTT P42858 2/20 0.54
CASP1 P29466 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
HSPA5 P11021 2/20 0.54
ALOX12 P18054 2/20 0.54
MEN1 O00255 1/20 0.54
SLC22A1 O15245 1/20 0.54
USP2 O75604 1/20 0.54
LMNA P02545 1/20 0.54
HSP90AA1 P07900 1/20 0.54
MAPT P10636 1/20 0.54
HSPD1 P10809 1/20 0.54
IDO1 P14902 1/20 0.54
BLM P54132 1/20 0.54
HSPE1 P61604 1/20 0.54
KMT2A Q03164 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13416170 0.91 HIF1A (0.55) ALOX15HIF1AHPGDCYP3A4HTT
SCHEMBL1858652 0.83 HPGD (0.62) ALOX15HIF1AHPGDCYP3A4HTT
SCHEMBL25335 0.83 ALOX15 (0.52) ALOX15HIF1AHPGDCYP3A4HTT
SCHEMBL7976544 0.83 ALOX15 (0.52) ALOX15HIF1AHPGDCYP3A4HTT
SCHEMBL29870381 0.83 ALOX15 (0.52) ALOX15HIF1AHPGDCYP3A4HTT
SCHEMBL2743858 0.81 ALOX15 (0.50) ALOX15HIF1AHPGDCYP3A4HTT
SCHEMBL11453783 0.81 ALOX15 (0.50) ALOX15HIF1AHPGDCYP3A4HTT
SCHEMBL14496519 0.81 ALOX15 (0.50) ALOX15HIF1AHPGDCYP3A4HTT
SCHEMBL15299051 0.81 ALDH1A1 (0.51) ALOX15HIF1AHPGDCYP3A4HTT
SCHEMBL82273 0.81 ALDH1A1 (0.54) ALOX15HIF1AHPGDCYP3A4HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230015875-A1 Ion Channel Antagonists/Blockers and Uses Thereof SHANGHAI EAST HOSPITAL (CN) 2023-01-19 US disclosed
CN-114401935-A Ion channel antagonists/blockers and uses thereof 上海市东方医院(同济大学附属东方医院) 2022-04-26 CN disclosed
WO-2021114313-A1 ION CHANNEL ANTAGONISTS/BLOCKERS AND USES THEREOF SHANGHAI EAST HOSPITAL (CN) 2021-06-17 WO disclosed
EP-2479203-A1 AROMATIC POLYESTER Muroran Institute of Technology (JP) 2012-07-25 EP disclosed
US-20120172570-A1 AROMATIC POLYESTER NITTA CORPORATION 2012-07-05 US disclosed
US-8129493-B2 Aromatic polyester MURORAN INSTITUTE OF TECHNOLOGY (JP) 2012-03-06 US disclosed
US-20110224343-A1 MODIFIER FOR AROMATIC POLYESTER AND AROMATIC POLYESTER RESIN COMPOSITION COMPRISING THE SAME MURORAN INSTITUTE OF TECHNOLOGY (JP) 2011-09-15 US disclosed
US-20110092662-A1 AROMATIC POLYESTER NITTA CORPORATION (JP) 2011-04-21 US disclosed
US-4196250-A DIBENZO CROWN COMPOUNDS, COCCIDIOSTATS, ANTIINFLAMMATORY AGENTS E. R. SQUIBB & SONS, INC. (US) 1980-04-01 US disclosed
US-4010252-A POLYQUATERNARY AMMONIUM COMPOUND, DEODORANTS COLGATE-PALMOLIVE COMPANY (US) 1977-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110224343-A1 MODIFIER FOR AROMATIC POLYESTER AND AROMATIC POLYESTER RESIN COMPOSITION COMPRISING THE SAME F12, PHAX, WDR82 ALOX15 1966/4885HIF1A 1324/4885HPGD 3275/4885
US-20230015875-A1 Ion Channel Antagonists/Blockers and Uses Thereof CACNA1F, CACNA1S, CACNA1D ALOX15 1017/4885HIF1A 2974/4885HPGD 633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.